Markets & Investing
How Psychedelics Inform this Hypnotherapist’s Practice
After healing a devastating neck injury with hypnotherapy, Collete Condorsita merged psychedelics and hypnotherapeutic techniques to direct neuroplasticity…
“Just because you’re in a neuroplastic state, doesn’t mean you’re actually making the changes in your life or thought patterns. You have to actually drive the train and do the work.”
Join us for Season 2 of Adventures of the Psyche: an exploration of the emerging frameworks and modalities that support the use of psychedelics.
In our second episode, we are joined by Collette Condorsita who shares how hypnotherapy helped her heal from a devastating neck injury, and the way psychedelics inform her hypnotherapeutic practice.
Colette Condorcita is a coach and guide who supports clients in accessing the subconscious and unconscious mind for support, insight, and personal growth. Colette utilizes a self-directed protocol to change unhealthy patterns with take-home hypnotherapeutic techniques to direct neuroplasticity and change. She is also an entrepreneur and regenerative designer with a background in regenerative agriculture and has been working and apprenticing with traditional curanderos in Latin America for over a decade. She is the founder of Decriminalize Nature Philadelphia (DNP), the Philly chapter working to decriminalize entheogenic plants and fungi.
Join filmmaker and host Mareesa Stertz for a brief visit into other realms where guests share personal stories of illumination, healing, and transformation through their use of psychedelics. See more Adventure of the Psyche episodes here.
The post How Psychedelics Inform this Hypnotherapist’s Practice appeared first on Lucid News.
psychedelics shares entrepreneur
-
Psychedelics1 week agoCybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
-
Law & Regulation1 week agoGoing concern warnings cloud Xtacy Therapeutics’ shrunk losses
-
Psilocybin1 week agoAre Shrooms Legal in Oregon: Full Guide
-
Psychedelics1 week agoOptimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
-
Psychedelics1 week agoAtai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
-
Psychedelics1 week agoPsyence Group’s NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
-
Law & Regulation1 week agoClearmind signs agreement with Hebrew University for psychedelic compound rights
-
Psychedelics6 days agoPsychedelics Can Offer More Than Therapy On Its Own